CARCINOMA, SQUAMOUS CELL OF HEAD AND NECK

Clinical trials for CARCINOMA, SQUAMOUS CELL OF HEAD AND NECK explained in plain language.

Never miss a new study

Get alerted when new CARCINOMA, SQUAMOUS CELL OF HEAD AND NECK trials appear

Sign up with your email to follow new studies for CARCINOMA, SQUAMOUS CELL OF HEAD AND NECK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1 Completed 1 Terminated 1

New cancer drug shows promise in advanced tumors

Disease control Ongoing

This study is testing whether an experimental drug called tisotumab vedotin, given alone or with other cancer drugs, can help control advanced solid tumors. It enrolled 352 people with advanced colorectal, lung, pancreatic, or head and neck cancers that had stopped responding to …

Matched conditions: CARCINOMA, SQUAMOUS CELL OF HEAD AND NECK

Phase: PHASE2 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

CARCINOMA, SQUAMOUS CELL OF HEAD AND NECK

Get alerted when new CARCINOMA, SQUAMOUS CELL OF HEAD AND NECK trials appear

New cancer drug shows promise in advanced tumors